The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 30, 2021

Filed:

Jan. 17, 2019
Applicant:

Medtronic Ardian Luxembourg S.a.r.l., Luxembourg, LU;

Inventors:

Michael Neidert, San Francisco, CA (US);

Paul Coates, Corte Madera, CA (US);

Robert L. Melder, Santa Rosa, CA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2006.01); G16H 40/63 (2018.01); A61B 5/11 (2006.01); A61B 5/0205 (2006.01); A61B 5/021 (2006.01); A61B 5/024 (2006.01); A61N 1/36 (2006.01); A61N 1/375 (2006.01); A61B 18/14 (2006.01); A61B 5/107 (2006.01); A61B 18/24 (2006.01); A61B 5/0538 (2021.01); A61B 18/18 (2006.01); A61B 18/00 (2006.01); A61B 5/0522 (2021.01);
U.S. Cl.
CPC ...
A61B 5/4836 (2013.01); A61B 5/0538 (2013.01); A61B 5/1076 (2013.01); A61B 5/6857 (2013.01); A61B 18/1492 (2013.01); A61B 18/1815 (2013.01); A61B 18/24 (2013.01); A61N 1/36007 (2013.01); A61N 1/36057 (2013.01); A61N 1/36117 (2013.01); A61N 1/37516 (2017.08); A61B 5/0522 (2013.01); A61B 5/4848 (2013.01); A61B 2018/00404 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00511 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/1861 (2013.01);
Abstract

Systems and methods for performing and assessing neuromodulation therapy are disclosed herein. One method for assessing the efficacy of neuromodulation therapy includes positioning a neuromodulation catheter at a target site within a renal blood vessel of a human patient and delivering neuromodulation energy at the target site with the neuromodulation catheter. The method can further include obtaining a measurement related to a dimension of the renal blood vessel via a sensing element of the neuromodulation catheter. The measurement can be compared to a baseline measurement related to the dimension of the renal blood vessel to assess the efficacy of the neuromodulation therapy. In some embodiments, the baseline measurement is obtained via the sensing element of the neuromodulation catheter prior to delivering the neuromodulation energy.


Find Patent Forward Citations

Loading…